No data are available on the cytologically and histologically demonstrated presence of intranodular chronic lymphocytic thyroiditis (ICLT) and on the ICLT relationship with thyroid nodule characteristics such as size, echotexture and nature (benign or malignant). We wished to fill this gap by analyzing data in a gender-specific fashion. We studied 408 thyroid nodules from 408 consecutive persons (325 females and 83 males). Nodules were isoechoic (n = 268) or hypoechoic (n = 140), ICLT +ve (n = 113 [27.7%]) or ICLT −ve (n = 295), cytologically low-risk (n = 197) or high-risk (n = 211), histologically benign (n = 263) or malignant (n = 145). ICLT +ve nodules were smaller than the ICLT −ve ones (15.4 ± 6.9 vs 20.9 ± 11.2 mm, P < 0.0001), a difference due to the isoechoic nodules (17.5 ± 6.5 vs 23.6 ± 11.7 mm, P = 0.0003). The smallest nodules were hypoechoic, cancerous and ICLT +ve nodules in males (9.5 ± 4.0 mm); the largest were isoechoic, cytologically risky and ICLT −ve in males (29.1 ± 13.2 mm). . ICLT +ve hypoechoic nodules of females and ICLT −ve hypoechoic nodules of males had the greatest rate of malignancy (67% both), while ICLT −ve isoechoic nodules of females had the lowest (19%).
No data are available on the cytologically and histologically demonstrated presence of intranodular chronic lymphocytic thyroiditis (ICLT) and on the ICLT relationship with thyroid nodule characteristics such as size, echotexture and nature (benign or malignant). We wished to fill this gap by analyzing data in a gender-specific fashion. We studied 408 thyroid nodules from 408 consecutive persons (325 females and 83 males). Nodules were isoechoic (n = 268) or hypoechoic (n = 140), ICLT +ve (n = 113 [27.7%]) or ICLT −ve (n = 295), cytologically low-risk (n = 197) or high-risk (n = 211), histologically benign (n = 263) or malignant (n = 145). ICLT +ve nodules were smaller than the ICLT −ve ones (15.4 ± 6.9 vs 20.9 ± 11.2 mm, P < 0.0001), a difference due to the isoechoic nodules (17.5 ± 6.5 vs 23.6 ± 11.7 mm, P = 0.0003). The smallest nodules were hypoechoic, cancerous and ICLT +ve nodules in males (9.5 ± 4.0 mm); the largest were isoechoic, cytologically risky and ICLT −ve in males ( [23.0%] ). ICLT +ve hypoechoic nodules of females and ICLT −ve hypoechoic nodules of males had the greatest rate of malignancy (67% both), while ICLT −ve isoechoic nodules of females had the lowest (19%).
In conclusion, presence/absence of ICLT is associated with some sexually dimorphic characteristics of thyroid nodules. Adding the specification of ICLT positivity/negativity in cytological reports may help improving the risk of malignancy at least in some groups of thyroid nodules.
thyroid gland can have various size (decreased, normal or increased) and various nodularity (absent or present, and if present consisting of one or more lesions). Moreover, like patients without HT, nodules can have various size and echotexture (anechogenous, isoechogenous, hypoechogenous or hyperechogenous). Finally, when nodules of HT patients are evaluated by fine-needle aspiration cytology (FNAC), their nature also varies, from one frankly benign with minimal risk of true cancer at thyroidectomy [colloid or cystic nodules] to one frankly malignant (PTC, most frequently) [2] . Regardless of cytological class of risk, numerous lymphocytes may or may not be detected in the punctured nodule.
To the best of our knowledge, there are no studies that have correlated the detection of CLT at the cytological interrogation of a thyroid nodule with other nodule characteristics, such as size, echotexture and nature (benign or malignant). To fill this gap, we conducted the study reported here.
Materials and methods
The study group consisted of 408 isoechoic or hypoechoic thyroid nodules from 408 consecutive persons (325 females and 83 males) living in southeastern Sicily and who were thyroidectomized during the years 2010 through 2016. Prior to thyroidectomy, nodules were evaluated by US-assisted FNAC, which was performed by the same operator (S.A.). S.A. was unaware of the serum thyroid autoantibody status. Cytology reading was also performed by S.A. Reasons for thyroidectomy were cytological diagnoses of malignancy, suspicious malignancy or probable malignancy (see below for diagnoses). For FNAC classes with lower malignancy risk, reasons were large thyroid size, presence/worsening of compressive symptoms or patient's decision.
In addition to echotexture (isoechoic vs hypoechoic), the other nodule characteristics that we considered, were: [i] size (maximum diameter in millimeters); [ii] FNAC category, with formation of two classes of risk of malignancy (low risk vs high risk); [iii] cytological picture consistent with chronic lymphocytic thyroiditis (CLT present vs CLT absent) regardless of FNAC category; [iv] histological diagnosis [benign vs malignant lesion]. All characteristics were analyzed in the background of gender (males vs females). Exclusion criteria were anechoic nodules, pseudonodules and nondiagnostic/unsatisfactory cytology Ultrasonography-assisted fine needle aspiration cytology (FNAC) Each nodule was aspirated at least twice using a 23-gauge needle. Smears were prepared and stained with hematoxylin and eosin (Papanicolau method). Nodules were classified according to class (or category) of risk and presence/absence of CLT in the smears. As it is common in Italy, we followed the classification of the British Thyroid Association/American Association of Clinical Endocrinologists/ Associazione Medici Endocrinologi (BTA/AACE/AME) [27, 28] . Because a revised Italian classification was published in the year 2014 [29] and our cohort spanned the years 2014-2016, all 408 cytological diagnoses adhered to the new classification [29] . This classification [29] considers six categories, from TIR1 (inadequate) to TIR5 (malignant), with the TIR3 category subdivided in two subcategories (TIR3A [indeterminate lesion of low risk] and TIR3B [indeterminate lesion of high risk]) that have different risk of malignancy (< 10% and 15-30%, respectively). In the equivalent six-category Bethesda system from category I ("Nondiagnostic or Unsatisfactory") through category VI ("Malignant"), TIR3A corresponds to "atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS), and TIR3B to "follicular neoplasm or suspicious for a follicular neoplasm (FN/SN), with corresponding risk of malignancy of ∼5-15% and 15-30%, respectively [30] . Inadequate cases (TIR1) were not included in our study.
For purposes of simplicity, data will be analyzed contrasting two, instead of five, categories of FNAC: the low risk (LR) and the high risk (HR) of malignancy. The low-risk group includes the TIR2 and TIR3A categories, while the high-risk group includes the TIR3B, TIR4 and TIR5 categories.
Intranodular CLT (ICLT) was diagnosed based on the typical features of a diffuse presence of lymphocytes in the background and/or infiltrating thyroid follicles with marked signs of inflammation and moderate amounts of colloid. Additional findings that could or could not be present were follicular atrophy, plasma cells, multinucleated giant cells, epithelioid cell clusters, intralobular fibrosis and Hurtle-cell metaplasia [6] . This metaplasia may display some chromatin clearing, nuclear atypia, nuclear grooves and prominent nucleoli sometimes overlapping with malignant lesions [31] . Cytological presence of ICLT was always confirmed at histology, and it was associated with serum positivity for thyroglobulin autoantibodies (TgAb) and/or thyroperoxidase autoantibodies (TPOAb) in approximately 80% of cases [data not shown], in agreement with a previous study [6] .
Statistics
Data are presented as mean ± SD. We compared continuous variables using the two-tailed Student's t test, and compared categorical variables using the chi-square test (χ 2 ) or Fisher's exact test, as appropriate.
Results
Results are summarized in Tables 1-4 The intergender significant difference in maximum diameter was accounted for by the isoechoic nodules (21.1 ± 9.8 mm [19] in females vs 26.6 ± 14.1 [23] in males vs P = 0.0006), not the hypoechoic nodules (13.9 ± 6.2 [12] in females vs 15.1 ± 5.9 [12] , P = 0.36. * N/A = Not applicable. In parentheses or in brackets are percentages of column or raw, respectively. For the maximum diameter of the nodules, as determined at ultrasonography, data are mean ± SD with median given in brackets. P values written boldface are statistically significant (P < 0.05 or lower), while P values written boldface italics are borderline significant (viz, comprised between 0.10 and 0.05).
Differences in gender
As said under Materials and Methods, the nodule we will refer to is the one that, in each patient, was considered worthy of FNAC, with subsequent thyroidectomy providing the final diagnosis. We will use interchangeably the terms "size" and "maximum diameter" of such nodule.
Of the 408 nodules, 325 were in females and 83 in males (F:M ratio = 3.9:1), and 113 (27.7%) had cytological and histological evidence of ICLT (Table 1) Gender distribution was also evaluated based on the echotexture of In parentheses or in brackets are percentages of column or raw, respectively. In the intergender comparison concerning the maximum diameter, such diameter of isoechoic nodules in females was different from that of males (21.1 ± 9.8 vs 26.6 ± 14.1 mm, P = 0.0006), whereas the corresponding comparison for the ICLT −ve nodules was similar (13.9 ± 6.2 vs 15.1 ± 5.9 mm, P = 0.36).
Table 3
Characteristics of thyroid nodules in the 408 patients as a whole or stratified based on intranodular chronic lymphocytic thyroiditis (ICLT). In parentheses or in brackets are percentages of column or raw, respectively. In the intergender comparison concerning the maximum diameter of ICLT +ve nodules, such diameter in females was similar to that in males (15.6 ± 6.8 vs 15.4 ± 6.4 mm, P = 0.93), whereas the corresponding comparison for the ICLT −ve nodules was significantly different (19.8 ± 10.0 vs 25.2 ± 13.9 mm, P = 0.0004).
the nodule. Of the 268 isoechoic nodules, 209 belonged to females and 59 to males, whereas of the 140 hypoechoic nodules, 116 belonged to females and 24 to males, with the corresponding F:M ratios being statistically similar (3.5:1 vs 4.8:1, P = 0.25). The US-measured maximum diameter of the nodule was also sexually dimorphic. Indeed, this diameter was approximately 5 mm larger in males than in females (Table 1, footnote) . In brief, compared to males, females had (i) an insignificantly greater likelihood of having nodules that are hypoeochoic (35.7% vs 28.9%, P = 0.25); (ii, iii) a borderline significantly lower or an insignificantly lower likelihood of having nodules with high-risk of malignancy at FNAC (49.5% vs 60.2%, P = 0.082) or conclusively malignant at histology (33.8% vs 42.2%, P = 0.16); (iv) a borderline statistically greater likelihood of having nodules that are ICLT +ve (29.8% vs 19.3%, P = 0.055). Not shown in Table 1 Table 3 ).
The frequency of histological malignancy was, as expected, greater in the hypoechoic nodules compared to the isoechoic nodules (55.7% vs 25.0%, P = 7.6 × 10 −10 , OR = 3.8 [2.4-5.8]; Table 2 ); it was also greater in ICLT +ve nodules compared to the ICLT −ve ones (48.7% vs 30.5%, P = 0.0006, OR = 2.16 [1.4-3.4], Table 3 ). The cytological and histological risks of malignancy based on combinations of two characteristics (echotexture and ICLT) are shown in , OR = 4.4 [2.3-8.5] ). This pattern was confirmed at histology, since the rates of malignancy in the hypoechoic ICLT +ve and isoechoic ICLT −ve groups were 37/58 (63.8%) and 49/ , OR = 5.9 [3.2-11.0]; Table 4 ). In turn, the said 75.9% frequency was greater than the 49.1% frequency (27/ . In males, the category of nodules hypoechogenous and ICLT −ve stand out because of the 100% rate of concordance, with 10 out of 10 nodules cytologically at high risk proving to be histologically malignant (Table 4) .
Relationship of the size of the nodules with their cytological or histological nature taking into account ICLT
The maximum diameter of the nodule differed, based on gender, echogenicity, absence/presence of ICLT, cytological diagnosis, and histological diagnosis (Fig. 1) . Based on combinations of these variables, the average maximum diameter varied greatly (Fig. 2) .
The mean size of nodules was almost 5 mm greater in males than females (23.3 ± 13.4 vs 18.5 ± 9.4 mm, P = 0.0002), 8.2 mm greater in isoechoic than hypoechoic nodules (22.3 ± 11.1 mm vs 14.1 ± 6.2 mm, P < 0.0001), this gap being wider in males (11.5 mm) compared to females (7.2 mm). The mean size was 5.5 mm greater in ICLT −ve compared to ICLT +ve nodules (P < 0.0001), again with an intergender difference (9.8 mm greater in males compared to 4.2 mm in females). The mean size was 2.5 mm greater in the cytologically low-risk compared to high-risk nodules (P = 0.02) and 4.3 mm greater in the histologically benign compared to the malignant nodules (P < 0.0001). Intergender differences were evident because the maximum diameter was consistently greater among males compared with females (2.5 mm in low-risk nodules [P = 0.24], 6.8 mm in high-risk [P < 0.001], 4.4 mm in benign [P = 0.01], and 6.4 mm [P = 0.0002] in malignant nodules) (Fig. 1) .
Taking into account the small representation of males in the ICLT +ve group, the smallest nodules belonged to males with hypoechoic, cancerous and ICLT +ve nodules (9.5 ± 4.0 mm [median = 10 mm], whereas the largest nodules belonged to males with isoechoic, cytologically risky and ICLT −ve nodules (29.1 ± 13.2 mm [median = 27]). Considering histology rather than cytology, the largest size (28.4 ± 13.1 mm [median = 24] ) is confirmed in the group of males/ isoechoic nodules/histologically malignant/ICLT −ve.
Discussion
Here we report that the nodule size was smaller in females and hypoechoic nodules. Plausible explanations could be genetic factors for the gender issue and diagnostic bias for the echotexture issue, because of a lower threshold of maximum diameter for FNA biopsy of hypoechoic nodules [32] , Most importantly, considering lack of data in the literature, we also report that the presence or absence of ICLT is associated with a number of different characteristics of thyroid nodules. First, presence of ICLT is twice more common in hypoechoic nodules than isoechoic nodules (41% vs 20%). As a result, the ratio of hypoechoic: isoechoic nodules in the ICLT +ve group is 1:1, but 0.4:1 in the ICLT −ve group. Second, ICLT +ve nodules are approximately 5 mm smaller than ICLT −ve nodules, but only in the isoechoic nodules. Third, the presence of ICLT appears to exert, depending on sex, a protective or non-protective action toward the nodule having a histologically confirmed malignant nature.
Because of a 2-fold larger representation of the hypoechoic feature in the ICLT +ve nodules compared to the ICLT −ve nodules (51% vs 28%), one would have expected a similar 2-fold difference in rates of malignancy. However, the difference was only 1.3-fold (64% vs 50%), and with a striking intergender pattern (1.5-fold in females [67% vs 46%] but 0.7-fold in males [44% vs 67%]).
In the present work on persons living in southeastern Sicily, upon studying a consecutive cohort of thyroid nodules interrogated by USassisted FNA and the defined histologically, we found that the combination of gender, echotexture and presence/absence of ICLT may influence not only the maximum diameter but also the cytological and histological nature of the thyroid nodule. One implication of our findings is the predictive usefulness of adding the presence or absence of ICLT in the cytological description of a thyroid nodule. One other implication is that predictivity has to take gender into account. For instance, as shown in Table 4 , among the same category of nodules (e.g., hypoechoic and ICLT +ve) the risk of histologically verified malignancy is two-thirds in females (67.3%) but just below one-half in males (44.4%), while among another category of nodules (isoechoic and ICLT +ve) the risk is reversed (18.6% in females but 36.5% in males).
Strengths of our study are that, to the best of our knowledge, a correlation study such as ours is unprecedented in the literature. In addition, patients come from the same geographical area (province of Siracusa, southeastern Sicily), and US-FNAC and cytological readings were performed by the same operator. There are limitations in the study, which we believe are difficult to address in subsequent investigations. As explained under Materials and Methods, our study is based on a series of patients who were thyroidectomized for cytological diagnoses of malignancy, suspicious malignancy or probable malignancy or, if the cytological category was low-risk, for mechanical reasons. This may introduce a bias in our study, because for the nodules of patients who were not operated we lack the information that we have for the nodules of patients who were thyroidectomized. Moreover, we cannot establish a cause-to-effect relationship between ICLT and the nodule characteristics. In other terms, we cannot state whether it is the initial appearance of CLT that determines the subsequent characteristics (size, echotexture, benign/malignant nature) or if it is some intrinsic characteristic of the nodule associated with any of the three said characteristics that determines the subsequent presence/absence of CLT. An answer would require a study based on frequent US and FNAC monitoring of persons who, at baseline have no thyroid nodules and no FNAC evidence of CLT, but then start developing nodules and CLT at different times. agencies in the public, commercial or not-for-profit sectors.
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